Literature DB >> 12207918

Abeta(25-35) and Abeta(1-40) act on different calcium channels in CA1 hippocampal neurons.

Catherine Rovira1, Nicolas Arbez, Jean Mariani.   

Abstract

The acute effects of beta-amyloid (25-35) and (1-40) on high voltage activated calcium channels were compared in CA1 pyramidal cells of adult mouse hippocampal slices using the whole-cell patch-clamp recording. Bath application of oligomeric beta-amyloid (25-35) reversibly increased the barium current (I(Ba)) to 1.61 (normalized amplitude), while oligomeric beta-amyloid (1-40) reversibly enhanced the I(Ba) to 1.74. Reverse-sequence beta-amyloid [(35-25) and (40-1)] had no effect. The effect of beta-amyloid (25-35) was blocked by nifedipine, a selective antagonist of L-type calcium channels. In contrast, the effect of beta-amyloid (1-40) was not blocked by nifedipine and I(Ba) was enhanced to 4.96. It is concluded that these oligomeric peptides may act through different types of calcium channels and/or receptors. The toxicity of Abeta(25-35) implicates a potentiation of L-type calcium channels while the one of Abeta(1-40) is related to an increase of non-L-type calcium channels, which may involve an increase in transmitter release.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12207918     DOI: 10.1016/s0006-291x(02)02072-7

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  22 in total

Review 1.  P/Q-type calcium channel modulators.

Authors:  V Nimmrich; G Gross
Journal:  Br J Pharmacol       Date:  2012-10       Impact factor: 8.739

2.  Effects of amyloid-β peptides on voltage-gated L-type Ca(V)1.2 and Ca(V)1.3 Ca(2+) channels.

Authors:  Sunoh Kim; Hyewhon Rhim
Journal:  Mol Cells       Date:  2011-08-04       Impact factor: 5.034

3.  Small molecule modulator of sigma 2 receptor is neuroprotective and reduces cognitive deficits and neuroinflammation in experimental models of Alzheimer's disease.

Authors:  Bitna Yi; James J Sahn; Pooneh Memar Ardestani; Andrew K Evans; Luisa L Scott; Jessica Z Chan; Sangeetha Iyer; Ashley Crisp; Gabriella Zuniga; Jonathan T Pierce; Stephen F Martin; Mehrdad Shamloo
Journal:  J Neurochem       Date:  2017-02       Impact factor: 5.372

Review 4.  Calcium signaling and amyloid toxicity in Alzheimer disease.

Authors:  Angelo Demuro; Ian Parker; Grace E Stutzmann
Journal:  J Biol Chem       Date:  2010-03-08       Impact factor: 5.157

5.  Neurotransmitter receptor and time dependence of the synaptic plasticity disrupting actions of Alzheimer's disease Aβ in vivo.

Authors:  Igor Klyubin; Tomas Ondrejcak; Jennifer Hayes; William K Cullen; Alexandra J Mably; Dominic M Walsh; Michael J Rowan
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-12-02       Impact factor: 6.237

6.  DL0410, a novel dual cholinesterase inhibitor, protects mouse brains against Aβ-induced neuronal damage via the Akt/JNK signaling pathway.

Authors:  Dan Zhou; Wei Zhou; Jun-Ke Song; Zhang-Ying Feng; Ran-Yao Yang; Song Wu; Lin Wang; Ai-Lin Liu; Guan-Hua Du
Journal:  Acta Pharmacol Sin       Date:  2016-08-08       Impact factor: 6.150

7.  The role of beta-amyloid protein in synaptic function: implications for Alzheimer's disease therapy.

Authors:  F Peña; Ai Gutiérrez-Lerma; R Quiroz-Baez; C Arias
Journal:  Curr Neuropharmacol       Date:  2006-04       Impact factor: 7.363

Review 8.  Calcium channel blockers and dementia.

Authors:  V Nimmrich; A Eckert
Journal:  Br J Pharmacol       Date:  2013-07       Impact factor: 8.739

Review 9.  Toxicity of amyloid beta peptide: tales of calcium, mitochondria, and oxidative stress.

Authors:  Laura Canevari; Andrey Y Abramov; Michael R Duchen
Journal:  Neurochem Res       Date:  2004-03       Impact factor: 3.996

10.  Amyloid-beta-induced ion flux in artificial lipid bilayers and neuronal cells: resolving a controversy.

Authors:  Ricardo Capone; Felipe Garcia Quiroz; Panchika Prangkio; Inderjeet Saluja; Anna M Sauer; Mahealani R Bautista; Raymond S Turner; Jerry Yang; Michael Mayer
Journal:  Neurotox Res       Date:  2009-03-19       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.